Literature DB >> 19941167

Heterogeneous prevalence of recurrent BRCA1 and BRCA2 mutations in Spain according to the geographical area: implications for genetic testing.

Orland Diez1, Sara Gutiérrez-Enríquez, Judith Balmaña.   

Abstract

BRCA1 and BRCA2 genes have a high allelic heterogeneity. The knowledge of the most prevalent mutations and their geographical distribution can be useful in designing efficient mutational screening. In the present work we reviewed the frequency of BRCA1 and BRCA2 recurrent mutations in seven geographic areas of Spain to evaluate the effects of their heterogeneous prevalence in genetic testing. We observed that prevalence of recurrent mutations vary according to the geographical origin of the studied families, and accounted for a variable number of positive families depending on the series. Therefore, more upcoming data of larger Spanish population cohorts collected from different areas in the country will allow to design a wider comprehensive panel of recurrent mutations that may be applicable worldwide to families with Hispanic origin.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19941167     DOI: 10.1007/s10689-009-9301-5

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  14 in total

1.  High proportion of novel mutations of BRCA1 and BRCA2 in breast/ovarian cancer patients from Castilla-León (central Spain).

Authors:  Mar Infante; Mercedes Durán; Eva Esteban-Cardeñosa; Cristina Miner; Eladio Velasco
Journal:  J Hum Genet       Date:  2006-06-07       Impact factor: 3.172

2.  BRCA1-2 mutations in breast cancer: identification of nine new variants of BRCA1-2 genes in a population from central Western Spain.

Authors:  Raquel Salazar; Juan Jesús Cruz-Hernandez; Enrique Sanchez-Valdivieso; César A Rodriguez; Amalia Gomez-Bernal; Elviradel Barco; Emilio Fonseca; Teresa Portugal; Rogelio Gonzalez-Sarmiento
Journal:  Cancer Lett       Date:  2006-02-20       Impact factor: 8.679

3.  Identification of the breast cancer susceptibility gene BRCA2.

Authors:  R Wooster; G Bignell; J Lancaster; S Swift; S Seal; J Mangion; N Collins; S Gregory; C Gumbs; G Micklem
Journal:  Nature       Date:  1995 Dec 21-28       Impact factor: 49.962

4.  Analysis of BRCA1 and BRCA2 in breast and breast/ovarian cancer families shows population substructure in the Iberian peninsula.

Authors:  A Vega; M Torres; J I Martínez; C Ruiz-Ponte; F Barros; A Carracedo
Journal:  Ann Hum Genet       Date:  2002-01       Impact factor: 1.670

5.  Differences in the frequency and distribution of BRCA1 and BRCA2 mutations in breast/ovarian cancer cases from the Basque country with respect to the Spanish population: implications for genetic counselling.

Authors:  E Beristain; C Martínez-Bouzas; I Guerra; N Viguera; J Moreno; E Ibañez; J Díez; F Rodríguez; G Mallabiabarrena; S Luján; J Gorostiaga; J L De Pablo; J L Mendizabal; M I Tejada
Journal:  Breast Cancer Res Treat       Date:  2007-01-30       Impact factor: 4.872

6.  Low frequency of recurrent BRCA1 and BRCA2 mutations in Spain.

Authors:  Gemma Llort; Carmen Yagüe Muñoz; Mercè Peris Tuser; Ignacio Blanco Guillermo; José Ramón Germà Lluch; Allen E Bale; Mayra Alvarez Franco
Journal:  Hum Mutat       Date:  2002-03       Impact factor: 4.878

7.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

8.  [BRCA1 and BRCA2 mutations in families studied in the program of genetic counselling in cancer of the Valencian community (Spain)].

Authors:  Eva Esteban Cardeñosa; Pascual Bolufer Gilabert; Sarai Palanca Suela; Eva Barragán González; Silvestre Oltra Soler; Isabel Chirivella González; Angel Segura Huerta; Carmen Guillén Ponce; Eduardo Martínez de Dueñas; Dolores Cuevas Cuerda; Dolores Salas Trejo
Journal:  Med Clin (Barc)       Date:  2008-02-09       Impact factor: 1.725

9.  Genetic analysis of BRCA1 and BRCA2 in breast/ovarian cancer families from Aragon (Spain): two novel truncating mutations and a large genomic deletion in BRCA1.

Authors:  M D Miramar; M T Calvo; A Rodriguez; A Antón; F Lorente; E Barrio; A Herrero; J Burriel; A García de Jalón
Journal:  Breast Cancer Res Treat       Date:  2008-01-04       Impact factor: 4.872

10.  Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.

Authors:  Orland Díez; Ana Osorio; Mercedes Durán; José Ignacio Martinez-Ferrandis; Miguel de la Hoya; Raquel Salazar; Ana Vega; Berta Campos; Raquel Rodríguez-López; Eladio Velasco; Javier Chaves; Eduardo Díaz-Rubio; Juan Jesús Cruz; María Torres; Eva Esteban; Andrés Cervantes; Carmen Alonso; Juan Manuel San Román; Rogelio González-Sarmiento; Cristina Miner; Angel Carracedo; María Eugenia Armengod; Trinidad Caldés; Javier Benítez; Montserrat Baiget
Journal:  Hum Mutat       Date:  2003-10       Impact factor: 4.878

View more
  13 in total

1.  Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers.

Authors:  Xavier Gabaldó Barrios; Mª Desamparados Sarabia Meseguer; Miguel Marín Vera; Ana Isabel Sánchez Bermúdez; José Antonio Macías Cerrolaza; Pilar Sánchez Henarejos; Marta Zafra Poves; Mª Rosario García Hernández; Encarna Cuevas Tortosa; Ángeles Aliaga Baño; Verónica Castillo Guardiola; Pedro Martínez Hernández; Isabel Tovar Zapata; Enrique Martínez Barba; Francisco Ayala de la Peña; José Luis Alonso Romero; José Antonio Noguera Velasco; Francisco Ruiz Espejo
Journal:  Fam Cancer       Date:  2017-10       Impact factor: 2.375

2.  BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.

Authors:  Inmaculada de Juan; Sarai Palanca; Asunción Domenech; Lidia Feliubadaló; Ángel Segura; Ana Osorio; Isabel Chirivella; Miguel de la Hoya; Ana Beatriz Sánchez; Mar Infante; Isabel Tena; Orland Díez; Zaida Garcia-Casado; Ana Vega; Àlex Teulé; Alicia Barroso; Pedro Pérez; Mercedes Durán; Estela Carrasco; M José Juan-Fita; Rosa Murria; Marta Llop; Eva Barragan; Ángel Izquierdo; Javier Benítez; Trinidad Caldés; Dolores Salas; Pascual Bolufer
Journal:  Fam Cancer       Date:  2015-12       Impact factor: 2.375

3.  Novel and recurrent BRCA1/BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the Program of Genetic Counseling in Cancer of Valencian Community (eastern Spain). Relationship of family phenotypes with mutation prevalence.

Authors:  Inmaculada de Juan Jiménez; Zaida García Casado; Sarai Palanca Suela; Eva Esteban Cardeñosa; José Antonio López Guerrero; Ángel Segura Huerta; Isabel Chirivella González; Ana Beatriz Sánchez Heras; Ma José Juan Fita; Isabel Tena García; Carmen Guillen Ponce; Eduardo Martínez de Dueñas; Ignacio Romero Noguera; Dolores Salas Trejo; Mercedes Goicoechea Sáez; Pascual Bolufer Gilabert
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

4.  Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome.

Authors:  Ingrid P Ewald; Patrícia Izetti; Fernando R Vargas; Miguel Am Moreira; Aline S Moreira; Carlos A Moreira-Filho; Danielle R Cunha; Sara Hamaguchi; Suzi A Camey; Aishameriane Schmidt; Maira Caleffi; Patrícia Koehler-Santos; Roberto Giugliani; Patricia Ashton-Prolla
Journal:  Hered Cancer Clin Pract       Date:  2011-12-20       Impact factor: 2.857

5.  Germline BRCA1 mutations increase prostate cancer risk.

Authors:  D Leongamornlert; N Mahmud; M Tymrakiewicz; E Saunders; T Dadaev; E Castro; C Goh; K Govindasami; M Guy; L O'Brien; E Sawyer; A Hall; R Wilkinson; D Easton; D Goldgar; R Eeles; Z Kote-Jarai
Journal:  Br J Cancer       Date:  2012-05-08       Impact factor: 7.640

6.  Mutations Causing Complex Disease May under Certain Circumstances Be Protective in an Epidemiological Sense.

Authors:  Sabine Siegert; Andreas Wolf; David N Cooper; Michael Krawczak; Michael Nothnagel
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

7.  Genetic testing in hereditary breast and ovarian cancer using massive parallel sequencing.

Authors:  Anna Ruiz; Gemma Llort; Carmen Yagüe; Neus Baena; Marina Viñas; Montse Torra; Anna Brunet; Miquel A Seguí; Eugeni Saigí; Miriam Guitart
Journal:  Biomed Res Int       Date:  2014-06-26       Impact factor: 3.411

8.  Hereditary breast and ovarian cancer in Andalusian families: a genetic population study.

Authors:  Bella Pajares; Javier Porta; Jose María Porta; Cristina Fernández-de Sousa; Ignacio Moreno; Daniel Porta; Gema Durán; Tamara Vega; Inmaculada Ortiz; Carolina Muriel; Emilio Alba; Antonia Márquez
Journal:  BMC Cancer       Date:  2018-06-08       Impact factor: 4.430

9.  Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain).

Authors:  Pilar Blay; Iñigo Santamaría; Ana S Pitiot; María Luque; Marta G Alvarado; Ana Lastra; Yolanda Fernández; Angeles Paredes; José M P Freije; Milagros Balbín
Journal:  BMC Cancer       Date:  2013-05-17       Impact factor: 4.430

10.  Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control.

Authors:  Ramūnas Janavičius
Journal:  EPMA J       Date:  2010-06-27       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.